Er Therapeutics Inc 最大收入來源為 Iron and Steel,在最近的收益報告中收入為 46,470,354,151。就地區而言,China 是 Er Therapeutics Inc 的主要市場,收入為 46,575,338,466。
Er Therapeutics Inc 是否盈利?
無,根據最新的財務報表,Er Therapeutics Inc 的淨損失為 $0
Er Therapeutics Inc 有負債嗎?
無,Er Therapeutics Inc 的負債為 0
Er Therapeutics Inc 的流通股有多少?
Er Therapeutics Inc 的總流通股為 57.73
關鍵數據
前收市價
$0.0001
開盤價
$0.0001
當日範圍
$0.0001 - $0.0001
52週區間
$0.0001 - $0.0025
交易量
1.0K
平均成交量
106
股息收益率
--
每股盈餘 (TTM)
-0.00
市值
$5.8K
什麼是 PNGM?
Pengram Corp. is an advanced gold exploration company. The company is headquartered in Bellingham, Washington and currently employs 0 full-time employees. The company went IPO on 2007-08-10. The firm has not realized any revenues from its planned operations. The firm is engaged in acquiring exploration and development of natural resource properties. The firm has not commenced business operations. The firm has interests in Clisbako claims and Eureka claims. The firm has 100% interest in a group of ten mineral claims, collectively known as the Clisbako claims, which are located in the Cariboo Mining Division of British Columbia, Canada. The firm also has 100% interest in a series of mineral claims referred to as the CPG Project, Fish Claims and The Golden Snow Property, collectively known as the Eureka claims, which are situated in the Eureka County, Esmeralda County and Mineral County, Nevada.